These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 18573422

  • 1. Immunological link between primary graft dysfunction and chronic lung allograft rejection.
    Bharat A, Kuo E, Steward N, Aloush A, Hachem R, Trulock EP, Patterson GA, Meyers BF, Mohanakumar T.
    Ann Thorac Surg; 2008 Jul; 86(1):189-95; discussion 196-7. PubMed ID: 18573422
    [Abstract] [Full Text] [Related]

  • 2. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
    Bharat A, Narayanan K, Street T, Fields RC, Steward N, Aloush A, Meyers B, Schuessler R, Trulock EP, Patterson GA, Mohanakumar T.
    Transplantation; 2007 Jan 27; 83(2):150-8. PubMed ID: 17264811
    [Abstract] [Full Text] [Related]

  • 3. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM, Davis RD, Hadjiliadis D, Hertz MI, Howell DN, Ward FE, Savik K, Reinsmoen NL.
    Transplantation; 2002 Sep 27; 74(6):799-804. PubMed ID: 12364858
    [Abstract] [Full Text] [Related]

  • 4. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection.
    Bharat A, Saini D, Steward N, Hachem R, Trulock EP, Patterson GA, Meyers BF, Mohanakumar T.
    Ann Thorac Surg; 2010 Oct 27; 90(4):1094-101. PubMed ID: 20868794
    [Abstract] [Full Text] [Related]

  • 5. Specific Donor HLA-DR Types Correlate With Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction.
    Haynes LD, Julliard WA, Mezrich JD, Leverson G, Meyer KC, Burlingham WJ.
    Transplantation; 2018 Jul 27; 102(7):1132-1138. PubMed ID: 29360666
    [Abstract] [Full Text] [Related]

  • 6. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
    Tikkanen JM, Singer LG, Kim SJ, Li Y, Binnie M, Chaparro C, Chow CW, Martinu T, Azad S, Keshavjee S, Tinckam K.
    Am J Respir Crit Care Med; 2016 Sep 01; 194(5):596-606. PubMed ID: 26967790
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience.
    Rao U, Sharma M, Mohanakumar T, Ahn C, Gao A, Kaza V.
    Transpl Immunol; 2019 Jun 01; 54():65-72. PubMed ID: 30794945
    [Abstract] [Full Text] [Related]

  • 8. Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.
    Saini D, Weber J, Ramachandran S, Phelan D, Tiriveedhi V, Liu M, Steward N, Aloush A, Hachem R, Trulock E, Meyers B, Patterson GA, Mohanakumar T.
    J Heart Lung Transplant; 2011 Jun 01; 30(6):624-31. PubMed ID: 21414808
    [Abstract] [Full Text] [Related]

  • 9. HLA and lung transplantation.
    Ju L, Suberbielle C, Li X, Mooney N, Charron D.
    Front Med; 2019 Jun 01; 13(3):298-313. PubMed ID: 29974325
    [Abstract] [Full Text] [Related]

  • 10. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
    Crespo E, Cravedi P, Martorell J, Luque S, Melilli E, Cruzado JM, Jarque M, Meneghini M, Manonelles A, Donadei C, Lloberas N, Gomà M, Grinyó JM, Heeger P, Bestard O.
    Kidney Int; 2017 Jul 01; 92(1):201-213. PubMed ID: 28274484
    [Abstract] [Full Text] [Related]

  • 11. Increased lung allograft failure in patients with HLA-specific antibody.
    Girnita AL, McCurry KR, Zeevi A.
    Clin Transpl; 2007 Jul 01; ():231-9. PubMed ID: 18637473
    [Abstract] [Full Text] [Related]

  • 12. The Impact of Donor-Recipient Human Leukocyte Antigen Matching on Bronchiolitis Obliterans-Free Survival Among Lung Transplant Recipients With Connective Tissue Diseases.
    Courtwright AM, Diamond JM, Sandorfi N, Goldberg HJ.
    Clin Transplant; 2024 Aug 01; 38(8):e15426. PubMed ID: 39136242
    [Abstract] [Full Text] [Related]

  • 13. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
    Iasella CJ, Ensor CR, Marrari M, Mangiola M, Xu Q, Nolley E, Moore CA, Morrell MR, Pilewski JM, Sanchez PG, McDyer JF, Zeevi A.
    J Heart Lung Transplant; 2020 Dec 01; 39(12):1417-1425. PubMed ID: 32981841
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients.
    Park JE, Kim CY, Park MS, Song JH, Kim YS, Lee JG, Paik HC, Kim SY.
    BMC Pulm Med; 2018 Mar 12; 18(1):45. PubMed ID: 29529999
    [Abstract] [Full Text] [Related]

  • 15. De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation.
    Safavi S, Robinson DR, Soresi S, Carby M, Smith JD.
    J Heart Lung Transplant; 2014 Dec 12; 33(12):1273-81. PubMed ID: 25130554
    [Abstract] [Full Text] [Related]

  • 16. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
    Smith MA, Sundaresan S, Mohanakumar T, Trulock EP, Lynch JP, Phelan DL, Cooper JD, Patterson GA.
    J Thorac Cardiovasc Surg; 1998 Nov 12; 116(5):812-20. PubMed ID: 9806388
    [Abstract] [Full Text] [Related]

  • 17. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
    Lobo LJ, Aris RM, Schmitz J, Neuringer IP.
    J Heart Lung Transplant; 2013 Jan 12; 32(1):70-7. PubMed ID: 23260706
    [Abstract] [Full Text] [Related]

  • 18. A novel mechanism for immune regulation after human lung transplantation.
    Mohanakumar T, Sharma M, Bansal S, Ravichandran R, Smith MA, Bremner RM.
    J Thorac Cardiovasc Surg; 2019 May 12; 157(5):2096-2106. PubMed ID: 31288367
    [Abstract] [Full Text] [Related]

  • 19. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
    Keller M, Bush E, Diamond JM, Shah P, Matthew J, Brown AW, Sun J, Timofte I, Kong H, Tunc I, Luikart H, Iacono A, Nathan SD, Khush KK, Orens J, Jang M, Agbor-Enoh S.
    J Heart Lung Transplant; 2021 Jun 12; 40(6):488-493. PubMed ID: 33814284
    [Abstract] [Full Text] [Related]

  • 20. Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation.
    Saini D, Angaswamy N, Tiriveedhi V, Fukami N, Ramachandran S, Hachem R, Trulock E, Meyers B, Patterson A, Mohanakumar T.
    J Heart Lung Transplant; 2010 Dec 12; 29(12):1330-6. PubMed ID: 20691611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.